Amit Arbune, Lauren Baldassarre, Ana Barac, Lauren Curry, Vedant Gupta, Gerhard Hildebrandt, Chaitanya Iragavarapu, Daniel Lenihan, Margaret Szabunio

Amit Arbune, MD, MHA, FACC

Assistant Professor, Advanced Cardiac Imaging and Cardio-Oncology
Gill Heart & Vascular Institute
University of Kentucky
Lexington, Kentucky

Amit Arbune, MD, MHA, FACC, is a cardiologist with a special interest in cardiac care for cancer patients.

Dr. Arbune received his medical degree from MGM Medical College in India. He holds a master’s in healthcare administration from the University of Kentucky and completed his Internal Medicine Residency at Northeast Ohio Medical University – St. Elizabeth Health Center in Youngstown, Ohio. Arbune completed his Cardiovascular Disease Fellowship at Case Western Reserve University – MetroHealth Medical Center in Cleveland, Ohio, where he served as chief fellow, and an Advanced Cardiovascular Imaging Fellowship at Yale University – New Haven Medical Center in New Haven, CT.

Arbune has extensive experience in general cardiology, and advanced cardiovascular imaging. Having clinical and research experience in cardio-oncology at Yale University, he has a keen interest in cardiac care for cancer patients. Arbune has participated in numerous clinical research projects and presented at many national conferences.

Arbune is board certified in cardiovascular disease, internal medicine, echocardiography and nuclear medicine. He is a member of the American College of Cardiology, the American Society of Nuclear Cardiology, the American Society of Echocardiography, the Society of Cardiac Magnetic Resonance, the Society of Cardiovascular Computer Tomography and the International Cardio-Oncology Society.

Back to top

Lauren Baldassarre, MD

Director, Cardio-Oncology
Cardiology Director of Cardiac MR/CT
Yale New Haven Hospital/Smilow Cancer Center
Associate Professor
Cardiovascular Medicine, Radiology and Biomedical Imaging
Yale School of Medicine
New Haven, Connecticut

Dr. Lauren A. Baldassarre is Associate Professor of Cardiovascular Medicine and Radiology & Biomedical Imaging at Yale School of Medicine in New Haven, CT. She is the Director of the Yale Smilow Cancer Center Cardio-Oncology Program and the Cardiology Director of Cardiac MR/CT for Yale New Haven Hospital. She holds clinical and research expertise in the use of advanced multimodality cardiac imaging for the detection, management, and prevention of cardiotoxicity from cancer therapeutics.

She earned her MD at Georgetown University School of Medicine in Washington, DC and completed her internal medicine residency at New York-Presbyterian Weill Cornell Medical Center in NYC. This was followed by cardiology fellowship at Medstar Georgetown University-Washington Hospital Center, where she focused on multimodality cardiac imaging, with dedicated training in cardiac MRI and CT. She then completed an additional fellowship in advanced cardiac imaging and cardio-oncology at Memorial Sloan Kettering Cancer Center in NYC.

Dr. Baldassarre is a member of the American College of Cardiology Cardio-Oncology Section Leadership Council and is the Chair of the International Cardio-Oncology Society Imaging Work Group. She is the chair of the Society for Cardiovascular Magnetic Resonance Cardio-Oncology special interest group and is a member of the Society of Cardiovascular Computed Tomography cardio-oncology writing group. She has contributed to as well as lead prior and ongoing expert consensus documents and has other numerous publications within these fields. She has recent and current funded study in the investigation of advanced cardiac MRI techniques for detection of cardiotoxicity from cancer immunotherapy agents.

Back to top

Ana Barac, MD, PhD

Associate Professor of Medicine and Oncology at Georgetown University Director of the MedStar Heart and Vascular Institute's Cardio-Oncology
Washington, DC

Ana Barac, MD, PhD, is an Associate Professor of Medicine and Oncology at Georgetown University and the director of the MedStar Heart and Vascular Institute's Cardio-Oncology program. Her clinical and research interests focus on the mechanisms, diagnosis and treatment of cardiac complications of cancer therapies.

Dr. Barac is internationally recognized for her work on cardiovascular health in patients with cancer. She is the current and founding Chair of the American College of Cardiology (ACC) Cardio-Oncology Council. She also serves as the co-director of the ACC's annual Live Course on Advancing Cardiovascular Care in Oncology patient and was the chair of the Heart House Roundtable on Cardiovascular Disease and Cancer Treatment in February 2018. She is an Associate Editor of the Journal of Cardiovascular Translational Research, is on the Editorial Board of the Journal of the American College of Cardiology and serves as an Associate Editor of the new JACC: Cardio-Oncology.

Dr. Barac has a background in basic science research on signaling pathways and was a visiting research fellow at the National Institutes of Health. In 2013 she was awarded a KL2 Scholar Award from the Georgetown-Howard Universities Center for Clinical and Translational Science for investigation of cardiac function in women, BRCA-mutation carriers who were treated with anthracyclines.

She served as the cardiology principal investigator (PI) for the SAFE-HEaRt trial, an investigator-initiated study that investigates safety of HER2 targeted therapies in patients with HER2 positive breast cancer and reduced cardiac function.

Dr. Barac is a diplomate in Cardiovascular Disease and has advanced training in Cardiac Imaging, Echocardiography and Cardiac MRI.

Back to top

Lauren Curry, PharmD, BCOP

Assistant Professor
Clinical Pharmacist Specialist
University of Kentucky
Lexington, Kentucky

Dr. Curry received her Doctor of Pharmacy degree from Duquesne University’s Mylan School of Pharmacy. She then completed a PGY1 pharmacy practice residency and PGY2 oncology pharmacy residency at Wake Forest Baptist Health.

Dr. Curry’s clinical practice areas include inpatient and outpatient hematology and bone marrow transplant. Teaching activities include precepting students and residents on the inpatient hematology and bone marrow transplant services and in the ambulatory hematology clinic.

Back to top

Vedant Gupta, MD

Assistant Professor, Internal Medicine
University of Kentucky College of Medicine
Lexington, Kentucky

Dr. Gupta earned an MD from the University of Cincinnati College of Medicine in Cincinnati, Ohio. He completed an Internal Medicine residency at the Cleveland Clinic Foundation, serving as chief resident, followed by a fellowship in Internal Medicine Cardiology and Advanced Cardiac Imaging at the University of Kentucky Hospital.

He is certified by the American Board of Internal Medicine and the
American Board of Internal Medicine, Cardiovascular Disease.

Back to top

Gerhard Hildebrandt, MD

Professor, Medicine
University of Kentucky College of Medicine
Division Chief, Hematology and Blood & Marrow Transplantation
UK HealthCare
Lexington, Kentucky

Dr. Hildebrandt earned a medical degree from the Johannes Gutenberg University of Mainz Medical School, Germany. Upon completing his doctoral research thesis, he was awarded the "doctor medicinae" with magna cum laude. He completed a residency in Internal Medicine and a Hematology and Oncology fellowship at the University of Regensburg, Germany, and became Bone Marrow Transplant and Hematologic Malignancies Attending at the University of Regensburg. In 2009, he was awarded the "Habilitation", the highest academic qualification a scholar can achieve by own pursuit in Germany.

After moving to the United States, he was a faculty member at the Louisiana State University in Shreveport and at the University of Utah. He was the director of the bone marrow transplant program at LSUHSC Shreveport and director of the Utah Blood and Marrow Transplant program at the Huntsman Cancer Institute/University of Utah before moving to Kentucky.

He is a member of ASH, ASCO, ASBMT, AACR, the author of more than forty articles, books, and book chapters and is strongly involved in clinical trials.

Dr. Hildebrandt focuses on patients with cancers of the blood and lymph system, patients before and after blood or marrow stem cell transplantation, and on patients suffering from acute and chronic graft versus host disease.

Back to top

Chaitanya Iragavarapu, MD

Assistant Professor
Division of Hematology/BMT
University of Kentucky
Lexington, Kentucky

My name is Chaitanya Iragavarapu. I am a clinical fellow with the division of Blood & Marrow Transplantation at the Stanford Cancer Institute. I am a graduate from the Hematology & Medical Oncology fellowship and Internal Medicine residency programs sponsored by New York Medical College and prior to that had obtained my medical school diploma from Stanley Medical College, Chennai, India.

My training in Hematology & Medical Oncology at New York Medical College was directed by mentors from varied backgrounds with training across some of New York’s most well-known programs. With their guidance, I had the privilege of learning by emulation and practice in different settings enjoying interaction with patients from across the social spectrum. Caring for some of the most socio-economically vulnerable patients in New York City helped me develop a keen sense of offering socially sensitive care in keeping with the ideals of the patient.

In contradistinction, my training at Stanford has challenged me with diseases of incredible complexity in patients with tremendous insight into their disease. I have also experienced firsthand the recent paradigm changing nature of Chimeric Antigen Receptor T-cell (CAR-T) therapy with its own steep learning curve. All in all, my year at Stanford has been my most challenging year in my training but also the most fruitful and I believe that I currently possess a clinical skillset wherein I can be a strong asset to your institution.

In addition to my clinical activities, I have also had the opportunity to engage in scholarly work during my training years. Especially during my fellowship, I was involved in a wide range of activities including preparing a trial proposal for consideration for industry sponsorship. In addition, I engaged myself in developing a system to better manage oral chemotherapeutics in economically challenged patients being treated at a public community hospital. I am currently studying T-cell receptor sequencing in T-cell Non-Hodgkin Lymphoma (T-NHL) with my mentor at Stanford, Dr. Weng and hope to have it ready for presentation by the end of the year.

Back to top

Daniel Lenihan, MD

Cardio-Oncology Center of Excellence
Washington University
St. Louis, Missouri

Daniel Lenihan, MD, is a cardio-oncologist who specializes in cardiology, heart disease and advanced heart failure/cardiac transplant. His areas of interest include cardiotoxicity of cancer therapy, early phase clinical trials, amyloidosis, cardiomyopathy and cancer survivorship.

Back to top

Margaret Szabunio, MD, FACR

Professor, Radiology
University of Kentucky College of Medicine
Lexington, Kentucky

Dr. Szabunio earned a BA magna cum laude from Hunter College of The City University of New York and an MD from Hahnemann University Medical School in Philadelphia, Pennsylvnia. She completed a radiology residency and fellowship at Long Island Jewish Medical Center in New York. She is a Fellow of the American College of Radiology.

Prior to her recruitment to UK, Dr. Szabunio was Director of Breast Imaging at the University of South Florida and H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida.

Dr. Szabunio has held many leadership roles encompassing clinical service, education, and research. Currently, she serves as the Treasurer of the American Association for Women Radiologists and as the Alternate Counselor to the American College of Radiology for the Society of Breast Imaging.

Dr. Szabunio has received ten teaching awards, and has been an invited speaker at more than fifty professional, scientific, and public organizations and society meetings.

Back to top